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1. Introduction 
It is well known, that patients with epilepsy suffer from excessive daytime sleepiness, fatigue 
and insufficient sleep. These problems are often overlooked or referred to epileptic seizures or 
antiepileptic drugs. It should be noticed, that patients with epilepsy suffer from sleep 
disorders more often than general population (Bazil 2003). Health outcome of patients with 
comorbidity of epilepsy and sleep disorders is worse as sleep disorders may aggravate 
epilepsy. Changes in amount and severity of epileptic seizures may lead to 
pharmacoresistency of epilepsy in patients with untreated sleep disorders. That is the reason 
why attention to quality of sleep and daytime vigility in patients with epilepsy should be 
payed. The cooperation of neurologist, pneumologist, somnologist and psychologist is very 
important in correct management of patients with epilepsy and sleep disorders.  
Daytime sleepiness is defined as the inability to stay awake during waking episodes of the 
day. It results in unintended lapses into drowsiness or sleep. Sleepiness occurs mainly in 
boring situations. Sometimes it is associated with increase of total amnount of sleep without 
feeling of restoration. In most cases excessive daytime sleepiness (EDS) is a chronic 
symptom and it must occur for at least three months prior to diagnosis (ICSD-2, 2005).  
Excessive daytime sleepiness is often result of self-imposed sleep deprivation espetially in 
young people. More often it is effect of disturbed nocturnal sleep or misaligned circadian 
rhytms. It may be side effect of many often-used drugs, for example hypnotics or alcohol. 
Nocturnal sleep disturbances, which lead to EDS, should be carefully assessed and treated. 
In several conditions EDS is not an outcome of night-sleep loss and should be considered as 
primary hypersomnia of central origin. These hypersomnias according to ICSD-2 include 
narcolepsy with or without cataplexy, recurrent hypersomnia, idiopathic hypersomnia with 
or without long sleep time and hypersomnias due to different medical and neurological 
conditions. Narcolepsy with cataplexy is characretized with daytime sleepiness and 
unwanted episodes of sleep, which occur several times a day. The duration of episodes may 
vary from a few minutes to more than an hour, patients wake up refreshed. Cataplexy is 
paroxyzmal, abrupt and reversible loss of muscule tone often elicited with emotional 
experience. Manifestations of disociated REM sleep (sleep paralysis and hypnagogic 
halucinations) are also exposed (Chokverty, 1994). Narcolepsy without cataplexy is 
associated with snoozing in daytime, sleep paralysis and hypnagogic hallucinations may 
occur. Secondary narcolepsy may be caused by tumors of brain or multiple sclerosis, if 
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hypothalamus is harmed. Recurrent hypersomnia, Kleine-Levin syndrome, is characterized 
by atacs of hypersomnia, which lasts for several days and occur several times per year. 
Episodes are accompanied by disturbances of behaviour (agression), bulimia and 
hypersexiality. Idiopathic hypersomnia with long sleep time is characterized by constant 
and sever EDS with unrefreshing naps of up to four hours and prolonged major sleep 
episode up to 10 – 14 hours. There are great difficulties with morning waking up and sleep 
drunkeness. Idiopathic hypersomnia without long sleep time, or essential hypersomnia is 
characterized with constant and sever EDS, which results in unintended naps of 
nonrefreshing nature. Cataplexa is absent. The major sleep episode is either normal, or 
slightly prolonged (to 10 hours). Post-wakening confusion of often reported.  
Behaviorally induced insufficient sleep syndrome is another reason of EDS. A therapeutic 
trial of a longer sleep episode can reverse the symptoms. Hypersomnia has been described 
also in association with a large range of medical conditions, including head trauma, stroke, 
encephalitis, inflammatory conditions, tumors and neurodegenerative diseases as 
M.Parkinson (ICSD-2), (Overeem & Readings , 2010). 
1.1 Diagnostic evaluation of sleepiness in patient with epilepsy 
Obtaining an accurate 24-hour-sleep-wake history is extremly important. History should be 
focused also on relevant factors as medical history, compensation of epilepsy, type and 
frequency of epileptic seizures, their incidence according to circadian cycle and actual 
antiepileptic medication, or other drug and medication use. Also social, enviromental or 
psychological conditions, which may interfere with sleep quality, should be evaluated.  
Neurological examination in connection with neuroimaging methods (MRI) can detect 
cerebral leasions as the reason of sleep problems. Standard EEG evaluation is recommended 
to detect abnormalities in EEG activity and interictal epileptic discharges. Epworth Scale of 
Sleepiness (ESS) is widely used questionnaire to quantify severity of daytine sleepiness. 
Score above 9 indicates elevated daytime sleepiness (Johns, 1991).  
Multiple Sleep Latency Test (MSLT) can objectively evaluate daytime sleepiness. When used 
as diagnostic prosedure of central hypersomnia it should be done during the day after 
polysomnographically documented adequate night sleep, which lasts at least six hours and 
after two weeks of regular sleep. (Carscadon & Dement, 1982, American sleep disorders 
association, 1992) (ICSD-2, 2005). Evaluation of MSLT starts 1,5-3 hours after morning 
awakening and consists of 5, or at least 4 records of polysomnography, each lasting 
20minutes (Littner et al., 2005). Latency of sleep and occurence and latency of REM sleep is 
in each record noted. A mean sleep latency below five minutes is generally considered as 
indicative of sleepiness, latency over ten minutes is generally considered indicative of 
normal alertness (American Sleep Disorders Association, 1992).  
1.2 Correlation of sleep and epilepsy 
Relationship of sleep and epilepsy is complex and reciprocal. Epilepsy may distrub sleep 
with night and also daytime epileptic seizures. On the other hand sleep modulates 
probabality of epileptic discharges and seizures in different sleep stages.  
Specific types of epilepsy are bounded to specific part of sleep-wake cycle, as night sleep, 
awakening, or appear randomly during circadian rhytm. Typical night epilepsy is for example 
nocturnal frontal lobe epilepsy (Zucconi, 2007), juvenile myoclonical epilepsy is typically 
connected to awakening. Sleep deprivation elevates probabality of epileptic seizure (Bazil, 
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Malow & Sammaritano, 2002), what is widely used in EEG evaluation. Influence of 
antiepileptic medication on daytime vigility and quality of sleep is also important. 
Unrecognised primary sleep disorders, which cause fragmentation of sleep, may aggravate 
epilepsy and increase amount of epileptic seizures. Distinction of sleep-related epileptic 
seizures and non-epileptic paroxymal events in sleep is frequently problematic and requires 
careful diagnostic approach with video-polysomnography (Moráň, 2005).  
Unrecognised sleep-related generalised epileptic seizures disturb sleep achritecture as they 
cause arousals. Generalized epileptic seizures reduce total sleep time and elongate latency to 
REM sleep. Amount of NREM1 and NREM2 stages may be extended (Foldvary-Schaefer, 
2002). Partial epileptic seizures during sleep do not disrupt night sleep markedly, only in 
case of their secondary generalization (Dasheiff, 2003). Epileptic seizures during daytime 
influence night sleep too. They reduce REM sleep, what may be cause of fatigue in 
postparoxysmal period (Bazil, Castro & Walczak, 2000).  
Antiepileptic therapy is considered to have influence on daytime vigility and quality of 
sleep. Barbiturates and benzodiazepines have sedative effect and cause daytime sleepiness 
(Bazil, 2003, Rang & Dale, 1991). Carbamazepine also induces daytime sleepiness, elongates 
slow-wave sleep and reduces REM sleep, mainly in the beginning of medication. 
Approximately after one month of medication these effects are not more noticeable (Placidi 
et al., 2000). Valproate according to literature elongates NREM1 and abbreviates NREM2 
(Foldvary-Schaefer, 2009). It elevates number of arousals and elongates slow-wave sleep 
(Moráň, 2005). Put on weight may be unfavorable for patients with sleep apnoe syndrome 
(Moráň, 2003).  
Primidone abbreviates latency of sleep and may improve quality of sleep. Phenytoin extends 
NREM1 and NREM2, shorten REM period and multiplies arousals. Gabapentin improves 
sleep stability and elongates slow-wave sleep as well as REM sleep (Foldvary-Schaefer, 2009). 
Lamotrigine reduces NREM3 and NREM4 and elongates REM sleep (Foldvary, 2002). As 
alerting drug should be dosed early in the day. Sleep latency may be shortened by topiramate 
(Foldvary-Schaefer, 2009). Levetiracetam consolidates sleep and does not modify vigilance 
(Cicolin, 2006). According to othe study (Cho, Kim & Motamendi, 2011) levetiracetam increase 
sleep efficiency without major effects on sleep structure. Antiepileptic drugs may be helpful in 
treatment of some sleep disorders. For example gabapentin, carbamazepine or lamotrigine 
have good effect on restles leg syndrome (Garcia-Borreguero et al, 2002). 
1.3 Sleep disorders and epilepsy 
Exact evidence about incidence of sleep disorders in patients with epilepsy is not available, 
but it is supposed, that the amount is higher in patients with epilepsy than in general 
population. For example patients with partial epilepsy have twice higher appearence of 
sleep disorders as in healthy group (39% vs 18%) (Bazil, 2003). According to this study 
higher presence of sleep disorders did not correlate with antiepileptic therapy.  
According to Foldvary-Schaefer (2002) patients with epilepsy have problems with 
initialization of sleep and have worse quality of sleep. Meatiness of these problems, as well 
as wores control of epileptic seizures, was higher in group of patients with partial epilepsy.  
Some literature indicates, that patients with epilepsy have also higher appearance of sleep 
related breathing disorders than general population. Sleep apnoe syndromes are present in 
0,8 – 2,2% of general adult population (Marin et at., 1997), however 28-55% patients with 
epilepsy suffer for sleep related disorders (Foldvary, 2002).  
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Even 33% pacients with medically refractory epilepsy have sleep apnoe syndrome (Malow 
et al., 2000). Reason of higher appearance of sleep related breathing disorders in patients 
with epilepsy is not clear. It may be connected with higher weight of patients as effect of 
anticonvulsant therapy (Manni & Terzaghi, 2010), or changes of endocrine system 
(valproate). Sleep apnoe syndrome leads to fragmented macroarchitecture of sleep with 
repeated hypoxemia of brain in consequence of repeated apnoic episodes. This may cause 
higher frequency of epileptic seizures. It is important, that correct therapy of sleep apnoe 
syndrome (reduction of weight, indication of CPAP or BiPAP) may bring improvement of 
epilepsy (Foldvary, 2002).  
Sleep disorders should be considered especially when patient with epilepsy indicates 
hypersomnia, but has low frequency of epileptic seizures, is treated with monotherapy of 
antiepileptic drug and has low blood levels of medication.  
1.4 Management of patient with epilepsy and sleep disorders 
Patient with epilepsy and EDS reguires accurate evaluation to detect reason of hypersomnia. 
Compensation of epilepsy should be examined. EEG during daytime and overnight-EEG 
should detect interictal or ictal discharges. This may cause microarousals and fragmentation 
of sleep with secondary hypersomnia. Adjusting of antiepileptic medication should reduce 
amount of epileptic seizures and improve sleep. It is recommended to avoid antiepileptic 
therapy with sedative effects (barbiturates, benzodiazepines) and useless combination of too 
many antiepileptic drugs.  
Correct sleep hygiene and life-style with regular and sufficient night-sleep and optimal 
surroundings is also important (Bazil, 2003, Happe, 2003).  
Hypersomnia in patients with epilepsy may be caused by sleep apnoe syndrome. This 
should be considered particulary in obese patients with morning headache and 
hypertension. Diagnosis is estimated by polysomnography. According to literature 1/3 
patients with refractory epilepsy have obstructive sleep apnoe syndrome (Malow et al., 
2000). Correct therapy of sleep related breathing disorders may improve quality of sleep. 
Antiepileptic therapy, which increase weight (valproate) should be avoided, as it may 
worsten sleep apnoe syndrome (Bazil et al., 2002). 
Insomnia is another possible reason of daytime hypersomnia and fatigue of patients with 
epilepsy. It should be treated by behavioral and relaxation methods, improvement of sleep 
habits or by sedative drugs. If antiepileptic therapy is considered as reason of insomnia, 
then it should be taken only in morning.  
2. Objectives 
Targets of this study were:  
- to determine daytime sleepiness in patients with epilepsy by Epworth scale of 
sleepiness and Multiple Sleep Latency Test and compare it with healthy controls 
- to investigate sleep architecture of patients with epilepsy   and compare  changes with 
healthy controls 
- to find out, if detected changes of sleep architecture correlate  with some characteristics 
of epilepsy 
3. Methodology 
All patients underwent standard EEG evaluation with 21 canal EEG machine and 
distribution of electrodes according to system 10-20, duration of record was 20 minutes. 
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Noticed abnormalities were rated as regional or generalised, with continual of intermitent 
occurence. Appearance of epileptiform ictal or interictal discharges was noted. 
3.1 Methods used to examine daytime sleepiness 
In both groups (patients with epilepsy and healthy controls) we used a questionnaire 
Epworth Scale of Sleepiness (ESS) (Johns, 1991). By answering eight questions about 
probability of falling asleep in standard situations we came to the result, i.e. score of 
daytime sleepiness ranging from 0 to 24. Rate 0-9 is considered as normal value, above 9 as 
elevated daytime sleepiness and value above 16 is considered as remarkably elevated 
daytime sleepiness (Watanabe et al., 2003). 
All patients with epilepsy were evaluated by Multiple Sleep Latency Test (MSLT) 
(Carscadon & Dement, 1982) in order to objectivise the daytime sleepiness. The latency of 
sleep was measured in five 20 minute polysomnographic registrations in this test. Between 
the registrations the patient should be awake (Usui et al., 2008). Mean latency of sleep and 
appearance of REM sleep was noticed. Mean latency of sleep shorter than 6 minutes was 
considered as indicative of elevated sleepiness (American sleep disorders association, 1992).  
3.2 Methods used to register sleep architecture 
Nocturnal polysomnografy was used in both groups to evaluate quality of sleep. We used 
program Brain Quick System 98 for polysomnography. Scoring of sleep stages was done 
with Sleep View Rembrandt Sleep Analysis Program.  
Registration and scoring of sleep stages was done according to criteria of Manual of 
Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human 
Subjects (Rechtschaffen & Kales, 1968). We used four electrodes (C3, C4, O1, O2, A1, A2) in 
EEG registration. When topographical localization of epileptiform discharges was needed, we 
used 19 EEG electrodes located according to international system 10-20. Standard localization 
of electrodes for electrooculogram and electromyogram m.mentalis was used.  
The result of sleep analysis was hypnogram, amount of sleep stages (NREM S1, NREM S2, 
NREM S3+-S4, REM) in %, total sleep time in minutes and efficiency of sleep in %was marked. 
For purpose of registration of different abnormal movement manifestations (epilepsy, REM 
behavior diseases etc.), a video was recorded simultaneously with polysomnography. 
3.3 Characteristics of the group of patients with epilepsy 
We examined 100 patients with epilepsy who were admitted to the I. Neurology Clinic of 
Comenius University Hospital in Bratislava for diagnostic or therapeutic reasons in the 
period from January 2004 to January 2009. The group consisted of 49 men and 51 women, 
with the average age of 34.68 ± 13.55 years. Patients of the age 9 - 61 were included. Average 
duration of illness was 9.31 ± 9.93 years, ranging from 0.5 to 47 years. Medical history of 
duration and type of epilepsy was taken. International classification of epileptic seizures 
(1981, 1989) and International classification of epilepsy (1989) was used.  
According to this classification 50 patients had focal symptomatic epilepsy, 26 patients had 
focal cryptogenic epilepsy. Generalised symptomatic epilepsy was diagnosed by 15 pacients 
and 9 patients had generalised cryptogenic or idiopathic epilepsy (see Fig.1). 
Etiology of epilepsy was evaluated. Idiopathic or cryptogenic epilepsy have 35% patients 
and symptomatic epilepsy have 65% of patients. Detailed analysis of reasons of epilepsy in 
group of symptomatic patients showed these factors: 
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- vascular (stoke) had 13 patients (20%) 
- perinatal lesion of brain had 13 patients (20%) 
- prenatal damage of brain had 10 patients (15,4%) 
- injury and posttraumatic lesion had 6 patients (9,2%) 
- tumors of brain had 8 patients (12,3%) 
- multiple sclerosis and other demyelinization diseases of brain – 5 patients (7,7%) 
- residual damage of brain after inflammatory disease – 5 patients (7,7%) 
- arteriovenous malformation – 3 patients (4,6%) 
- exotoxic encefalopathy – 2 patients (3%) 
 
50
26
15
9
Foc. symp. epi Foc. crypt. + idiop. epi 
Gen. sympt. epi Gen.crypt.+idiopat. epi
 
Fig. 1. Amount of patients according to type of epilepsy 
Compensation of epilepsy was evaluated according to Diagnostic and therapeutic standard 
of epilepsy (Donáth, 1996). As insufficiently compensated epilepsy were rated patients with 
several epileptic seizures during last month. Partially compensated epilepsy had patients 
with minimally half of year seizure free period and fully compensated epilepsy had 
patients, who had not for last 3 years an epileptic seizure. According to these criteria 80 
patients had insufficiently compensated epilepsy and 20 patients were rated as having 
partially or fully compensated epilepsy.  
All patients were treated by antiepileptic medication. Monotherapy used 59 patients (59%), 
29 pacients (29%) were treated by two antiepileptic drugs (AEDs) and 12 pacients (12%) 
have three and more AEDs (see Fig.2). 
Most frequently used monotherapy was carbamazepine, which used 31 patients (it was 
52,5% of patients treated by monotherapy). Valproate as monotherapy used 14 pacients 
(23,7% of patients on monotherapy), 10 patient (16,9%) used lamotrigin, one pacient (1,7%) 
used primidon, one patient (1,7%) was treated by clonazepam, one patient (1,7%) 
gabapentin and one patient phenytoin (1,7%) (see Fig.3).  
Two AEDs were used by 29 patients. Most frequent combination of EADs was 
carbamazepine /valproate, which used 9 patients (31 % of all patients on combination of 
two AEDs). Next most commonly used combination of two AEDs was valproate/ 
lamotrigine used by 6 patients (20,7% of all patients on combination of two AEDs). Three 
www.intechopen.com
 
Daytime Sleepiness and Changes of Sleep in Patients with Epilepsy 
 
35 
patients used combination of lamotrigine/topiramate. Two patients used combination of 
carbamazepine/lamotrigine, carbamazepine/topiramate and combination valproate/ 
topiramate. One patient used combination carbamazepine/levetiracetam, carbamazepine/ 
gabapentin, carbamazepine/pregabalin, valproate/levetiracetam and topiramate/ 
zonisamid (see Table 1).  
 
 
59.00%
29.00%
12.00%
Monotherapy AED Two AEDs Three and more AEDs
 
Fig. 2. Antiepileptic therapy in group of epileptic patients.  
 
 
52%
23%
17%
2%2%2%2%
Carbamazepine Valproate Lamotrigine
Primidon Clonazepam Gabapentin
Phenytoin
 
 
 
Fig. 3. Antiepileptic monotherapy in group of epileptic seuzures.  
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Carb. + + + + + + + + + + + + + + + +              
Valpr. + + + + + + + + +        + + + + + + + + +     
Lamic.          + +      + + + + + +    + + +  
Topir.            + +          + +  + + + + 
Levet.              +           +     
Zonis.                             + 
Gabap               +               
Pregab                +              
Table 1. Combinations of two AEDs  used in the group of patients with epilepsy.  
Combination of three and more AEDs was used by 11 patients. Most commonly used 
combination of AEDs was carbamazepine/ valproate/lamotrigine, which used 7 pacientov, 
next combinations see in table 2.  
 
Carbam. + + + + + + + + + + + + 
Valproate + + + + + + + + + + +  
Lamotrig. + + + + + + +     + 
Topiramate          +  + 
Levetirac.           +  
Clonazepam        + +    
Benzodiaz.            + 
Table 2. Combinations of three and more AEDs used in the group of patients with epilepsy.  
The relation of seizures and sleep or waking state was examined in all patients suffering 
from epilepsy. On this basis, patients were divided into two groups. The first group of 17 
patients had seizures between 10.00 p.m. and 7.00 a.m. which means during sleep or on 
awakening. The second group of 83 patients had predominantly or exclusively seizures 
related to waking hours. 
3.4 Characteristics of the control group 
Control group was composed by 80 healthy persons without anamnesis of epilepsy. They 
were admitted to the I. Neurology Clinic of Comenius University Hospital in Bratislava for 
low back pain and in time of evaluation were without pain, which could interfere with 
sleep. The group consisted of 45 women and 35 men with everage age 38,75 ±14,32 year, 
including 17 - 78 years.  
4. Stastistical methods 
The standard box-and-whisker plots were used for graphical representation of the 
parameter distribution in the particular groups of patients (Rousseeuw et al., 1999). 
Normality of data was verified by the Lilliefors test (Conover, 1999). To compare the 
observed parameters, the parametric method unpaired Student's group t-test was used 
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(Kirkwood, 2003; Dušek, 2009). As the non-parametric statistical methods we used the 
Kruskal - Wallis H test and the Kolmogorov-Smirnov test. (Gibbons and Subhabrata, 2003) 
5. Results 
5.1 Changes in daytime sleepiness 
Mean value of ESS in the group of patients with epilepsy was 7,11 ± 4,54, in control group 
5,53 ± 2,15. Both mean values were in physiological range (under 9). Through that mean 
value of ESS was higher in group with epilepsy and the difference against control group 
was significant on p< 0,05 confirmed by all three used stastistical methods (see figure 4, 
table 3, 4). This result is assesed as significant tendency to daytime sleepiness in patients 
with epilepsy.  
 
 
Fig. 4. Values of score Epworth Scale of Sleepiness (ESS) in the control group (0) and in the 
group of patients with epilepsy (1). The difference is statistically significant (p<0,05). 
 
 nubmer Mean value SD 
Min 
value 
Max 
value 
Median 
Lilliefors 
test  (p) 
ESS 
control 
group 
80 5,53 2,15 1 9 5,5 0,003488 
ESS 
Epilep. 
100 7,11 4,54 0 21 6,0 0,001938 
Table 3. Values of score ESS and statistical parameters in cotrol group and group of patients 
with epilepsy.  
 t-test Kruskal-Wallis Kolmogorov-Smirnov 
p 0,00261226* 0,047123469* 0,000152915* 
Table 4. Statistical comparison of values ESS by Students t-test, Kruskal-Wallis test a 
Kolmogorov-Smirnovov test. All result are statistically significant.  
www.intechopen.com
 
Novel Aspects on Epilepsy 
 
38
5.2 Changes in sleep architecture 
In control group and group of patients with epilepsy statistical parameters as effectivity of 
sleep, amount of NREM S1, S2, S3+4, REM, latency to NREM S1 and latency to REM sleep 
were evaluated. Normality of distribution of data was tested by Lilliefors test and tests like 
Student’s t-test, Kruskal-Wallis test and Kolmogor-Smirnov test were used (see tables 5a,  
5b, 5c)  
 
 
 nubmer average SD 
Min 
value 
Max 
value 
Median 
Lilliefors 
(p) 
Eff. of 
sleep /%/ 
80 87,38 9,89 50 99 90,5 0,001 
S1 /%/ 80 26,39 12,62 1,4 60,7 25,2 0,5 
S2 /%/ 80 29,40 10,10 12,3 49,9 28,7 0,14 
S3,S4 /%/ 80 21,02 9,34 0,1 48,9 19,35 0,002 
REM /%/ 80 23,06 9,96 0 47,8 24,95 0,02 
Lat. to S1 
/min/ 
80 27,58 28,18 2 123,5 15,5 0,001 
Lat. to 
REM /min/ 
79 132,64 67,04 21,5 372 118 0,001 
 
(SD – standard deviation)  
Table 5a. Descriptive characteristics in the control group   
 
 
 nubmer average SD Min value Max value Median 
Lilliefors 
(p) 
Eff. of 
sleep /%/ 
100 77,10 15,06 30 98 80 0,001 
S1 /%/ 99 22,75 11,29 1,3 48,5 21 0,34 
S2 /%/ 100 38,77 12,83 12,8 68,9 36,55 0,17 
S3,S4/%/ 100 19,13 9,28 0,23 43 17,95 0,003 
REM /%/ 100 18,82 9,06 1,9 54,3 18,05 0,30 
Lat. to S1 
/min/ 
100 41,55 60,23 1,5 386,5 20,5 0,001 
Lat. to 
REM 
/min/ 
98 163,26 94,75 33 454,5 137 0,001 
 
(SD – standard deviation) 
Table 5b. Descriptive characteristics in the group of patients with epilepsy  
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t-Test 
(p) 
Kruskal-Wallis 
(p) 
Kolmogorov-Smirnov 
(p) 
Eff. of sleep /%/ 1,3509E-07* 6,23404E-07* 3,84773E-05* 
S1 /%/ 0,046 0,066 0,230 
S2 /%/ 1,42639E-07* 1,29334E-06* 1,04321E-05* 
S3,S4/%/ 0,179 0,163 0,304 
REM /%/ 0,004* 0,001* 0,0008* 
Lat. to S1 /min/ 0,042 0,346 0,346 
Lat. to REM /min/ 0,013* 0,047* 0,004* 
Table 5c. Comparison of observed characteristics in the control group and in the group of 
patients with epilepsy 
Patients with epilepsy have significantly lower effectivity of sleep than healthy controls on 
statistical significance p< 0,001* (see figure 5a). Furthermore patients with epilepsy have 
significantly more NREM S2 sleep, fewer REM sleep and have significantly longer latency to 
first REM sleep in comparison to healthy controls (see figures 5b, 5C, 5d). Other differences 
were not significant.  
 
 
 
 
 
Fig. 5a. Effecitvity of sleep in the control group (0) and in the group of patients with epilepsy 
(1). The difference is statistically significant (p< 0,001). 
Significant changes in sleep architecture of patients with epilepsy were observed. Lower 
effectivity of sleep together with higher amount of NREM S2 sleep and fewer REM sleep 
may have considerable consequences on quality of life of patients with epilepsy.  
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Fig. 5b. Value of NREM S2 (%) in the control group (0) and in the group of patients with 
epilepsy (1). The difference is statistically significant (p< 0,001). 
 
 
 
 
Fig. 5c., 5d. Value of REM (%) and latency to REM sleep (minutes) in the control group (0) 
and in the group of patients with epilepsy (1). The differences are statistically significant.  
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5.3 Evaluation of factors with possible influence on sleep architecture of patients with 
epilepsy 
Some characteristics of epilepsy, like type of epilepsy, it’s etiology, antiepileptic medication, 
actual compensation of seizures or evidence of ictal discharges may have influence on 
quality of sleep. We have chosen some of these factors with purpose to try to find reasons of 
different characteristics of sleep in patients with epilepsy. Parameters of ESS, MSLT and 
sleep macroarchitecture were evaluated and statistically compared.  
5.3.1 Influence of antiepileptic medication on daytine sleepiness and architecture of 
sleep 
All patients with epilepsy in monitored group were treated by AEDs. As the first step 55 
patients with monotherapy AEDs were evaluated. In this group 14 patients were treated by 
valproate, 31 patients by carbamazepine and 10 patients by lamotrigine. Parameters of ESS, 
MSLT, effectivity of sleep, % portions of sleep stages NREM S1, S2, S3+4, REM sleep and 
latency to NREM S1 sleep and latency to REM sleep were examined and statistically 
compared. No significant differences were ascertained, only patients treated by 
carbamazepine had higher score of ESS, more % portion of S1 NREM stage, less % portion of 
deep S3+S4 NREM sleep and had longer latency to first REM stage in comparison with 
patients treated only by valproate or lamotrigine (see figures 6a, 6b, 6c and 6d). These 
results may indicate some negative effect of carbamazepine on quality of daytime vigility 
and sleep.  
 
 
Fig. 6a. Values of ESS in the group of patients with valproate (0), carbamazepine (1) and 
lamotrigine (2). Differences are not statistically significant. 
As the next step, characteristics of daytime sleepiness and quality of sleep in the group of 
patients with monotherapy and the group of patients on two and more AEDs were 
evaluated and compared. We supposed, that combination of two and more AEDs could 
disturb night sleep and worsten daytime vigility. Group of patients using monotherapy 
consisted of 55 parients, in next group with more AEDs were 45 patients. Observed 
parameters are presented in tables 6a, 6b.  
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Fig. 6b., 6c. Portion of S1 NREM sleep and S3+S4 NREM sleep in the group of patients with 
valproate (0), carbamazepine (1) and lamotrigine (2). Differences are not statistically 
significant. 
 
 
Fig. 6d. Latency to first REM sleep in the group of patients with valproate (0), 
carbamazepine (1) and lamotrigine (2). Differences are not statistically significant. 
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 number mean SD 
Min 
value 
Max 
value 
Median 
Lilliefors 
test (p) 
ESS 55 6,58 4,36 1 19 6 0,001 
MSLT 
/min/ 
38 12,87 5,18 3,2 20 14,1 0,09 
Eff. of 
sleep /%/ 
55 76,45 15,08 30 98 79 0,012 
S1 /%/ 55 22,99 11,45 1,3 48,5 20,8 0,039 
S2 /%/ 55 38,39 13,29 15,3 67,9 36,7 0,5 
S3+S4 
/%/ 
55 18,50 9,63 0,23 40 17,3 0,23 
REM /%/ 55 19,75 9,79 1,9 54,3 20 0,40 
Lat. to S1 
/min/ 
55 40,12 58,08 1,5 386,5 18,5 0,001 
Lat. to 
REM 
/min/ 
55 161,38 90,79 33 454,5 139,5 0,002 
(SD –standard deviation) 
Table 6a. Descriptive characteristics of patients with monotherapy of antiepileptic drugs.  
 
 number mean SD 
Min 
value 
Max 
value 
Median 
Lilliefors 
test (p) 
ESS 45 7,88 4,73 0 21 8 0,46 
MSLT 33 12,9 5,15 3,1 20 13,6 0,30 
Ef.sp. 
/%/ 
45 78,02 15,17 38 98 81 0,05 
S1 /%/ 45 22,39 11,20 1,6 46,6 23,3 0,23 
S2 /%/ 45 39,33 12,28 12,8 68,9 36,4 0,14 
S3+S4 
/%/ 
45 20,04 8,79 7,9 43 18,7 0,002 
REM 
/%/ 
45 17,49 7,80 7,4 32,7 15,7 0,22 
Lat.po 
S1 
/min/ 
45 43,61 63,88 2 386,5 23,5 0,001 
Lat.po 
REM 
/min/ 
45 165,88 101,08 49 453 125 0,001 
(SD –standard deviation) 
Table 6b. Descriptive characteristics of patients with therapy of two and more AEDs.  
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Table 6c shows statistical comparison of evaluated parameters in both groups. Differences 
are not significant.  
 
 
t-Test 
(p) 
Kruskal-Wallis 
(p) 
Kolmogor-Smirnov 
(p) 
ESS 0,17 0,12 0,06 
MSLT 0,98 0,96 0,10 
Eff. of sleep /%/ 0,61 0,49 0,90 
NREM S1 /%/ 0,79 0,88 0,72 
NREM S2 /%/ 0,72 0,96 0,57 
NREM S3+S4 /%/ 0,41 0,50 0,66 
REM /%/ 0,20 0,29 0,28 
Lat. to S1 /min/ 0,78 0,63 0,63 
Lat. to REM /min/ 0,82 0,10 0,89 
Table 6c. Comparison of observed parameters in the group of patients on monotherapy and 
the group with two and more AEDs.  
Though patients in the group with combination of AEDs have lightly elevated score ESS 
(ESS 7,88 ± 4,74) in comparison of patients on monotherapy (ESS 6,58 ± 4,36), the difference 
was not significant (see figure 7). Neither of other evaluated differences was significantly 
different.  
 
 
Fig. 7. Values of ESS in the group with monotperapy (0) and the group with two and more 
AEDs (1). The difference is not significant.  
5.3.2 Influence of type of epilepsy (focal/generalized) on daytime sleepiness and 
quality of sleep 
Epileptogenesis of focal and generalized epilepsy is diverse. In focal epilepsy epileptic 
discharge is localizated and placement of epileptic focus is important as well as possible 
secondary generalization. Primary generalized epilepsies have different mechanism of 
epileptigenesis with involvement of bigger areas of the brain. It was expected, that focal and 
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generalized epilepsies have also different influence on sleep architecture. Group of 100 
patients with epilepsy was divided in two groups. Group of patients with focal epilepsy 
inclosed 76 patients, in group of generalized epilepsy were 24 patients. Tables 7a, 7b and 7c 
describe results of ESS, MSLT, effectivity of sleep and other characteristics of sleep.  
 
 
 
 
number mean SD Min value Max value Median
Lilliefors test 
(p) 
ESS 76 7,22 4,50 0 21 6 0,008 
MSLT 56 12,64 5,02 3,1 20 13,15 0,30 
Eff. of 
sleep /%/ 
76 78,60 13,78 38 98 81 0,007 
S1 /%/ 75 23,88 11,54 1,3 48,5 22,9 0,5 
S2 /%/ 76 39,34 12,88 12,8 68,9 36,95 0,14 
S3+S4 /%/ 76 17,80 8,61 0,23 43 17,1 0,006 
REM /%/ 76 18,79 9,55 1,9 54,3 17,45 0,37 
Lat. to S1 
/min/ 
76 36,67 52,87 1,5 386,5 18,5 0,001 
Lat. to 
REM 
/min/ 
75 165,61
101,0
5 
36 454,5 125 0,001 
Table 7a. Descriptive characteristics of group with focal epilepsy.  
 
 numbert mean SD Min value Max value Median
Lilliefors test 
(p) 
ESS 24 6,75 4,73 0 15 5,5 0,05 
MSLT 15 13,79 5,59 3,2 20 15 0,05 
Eff.of 
sleep /%/ 
24 72,32 18,07 30 98 76,5 0,45 
S1 /%/ 24 19,22 9,89 3,1 39,8 19,9 0,50 
S2 /%/ 24 36,97 12,77 15,3 57,4 35,65 0,50 
S3+S4 /%/ 24 23,35 10,23 2,5 40 21,9 0,33 
REM 24 18,92 7,47 6,9 34,8 19,1 0,50 
Lat. to S1 
/min/ 
24 57 78,58 3 386,5 36,75 0,001 
Lat. to 
REM 
/min/ 
23 155,61 71,81 33 333 139,5 0,05 
Table 7b. Descriptive characteristics of group with primary generalized epilepsy.  
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t-test 
(p) 
Kruskal-Wallis 
(p) 
Kolmogor-Smirnov 
(p) 
ESS 0,67 0,61 0,89 
MSLT 0,48 0,37 0,45 
Eff. of sleep /%/ 0,02* 0,01* 0,005* 
NREM S1 /%/ 0,06 0,10 0,43 
NREM S2 /%/ 0,43 0,50 0,36 
NREM S3+S4 /%/ 0,02* 0,01* 0,008* 
REM /%/ 0,94 0,69 0,82 
Lat. to S1 /min/ 0,24 0,09 0,16 
Lat. to REM /min/ 0,61 0,74 0,42 
Table 7c. Comparison of observed parameters in the group with focal epilepsy and the 
group with generalized epilepsy.  
It was detected, that patients with generalized epilepsy have lower effectivity of sleep and 
patients with focal epilepsy have fewer deep sleep stages of NREM sleep. These differences 
are statistically significant. Figures 8a, 8b show these results.  
This may be result of different mechanism of epileptogenesis in both types of epilepsy, 
though further study should be done to exlpain these differences.  
 
 
 
 
 
Fig. 8a. Effectivity of sleep in the group of focal epilepsy (0) and the group of generalized 
epilepsy (1). The difference is statistically significant. 
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Fig. 8b. Portion of S3+S4 NERM sleep in the group of focal epilepsy (0) and the group of 
generalized epilepsy (1). The difference is statistically significant. 
5.3.3 Influence of localization of epileptic focus on daytime sleepiness and 
architecture of sleep 
Localization of epileptic focus in the group of patients with focal epilepsy was determined 
by EEG evaluation. Correct localization of epileptic focus was possible by 72 patients. The 
rest of patients had multiple foci or normal EEG. 
Group of 72 patients was divided into two parts. In the first group 61 patients had focus in 
temporal or temporoparietal region. Next group of 11 patients had focus in frontal or 
frontotemporal region. Characteristics of daytime vigility and night sleep were compared in 
both groups. Results are presented in tables 8a, 8b and 8c.  
 
 Number Mean SD Min value Max value Median 
Lilliefors 
test (p) 
ESS 61 7,28 4,39 0 19 6 0,02 
MSLT 44 12,20 4,84 4,5 20 11,9 0,42 
Eff. of 
sleep /%/ 
61 78,36 13,49 38 98 81 0,002 
S1 /%/ 60 23,34 11,83 1,3 48,5 21,9 0,50 
S2 /%/ 61 39,21 13,03 12,8 68,9 36,7 0,14 
S3+S4 
/%/ 
61 17,84 8,90 0,23 43 16,9 0,002 
REM /%/ 61 19,40 9,86 1,9 54,3 18,8 0,50 
Lat. to S1 
/min/ 
61 38,09 56,28 1,5 386,5 19,5 0,001 
Lat. to 
REM 
/min/ 
60 163,59 97,35 36 454,5 135 0,007 
(SD –standard deviation) 
Table 8a. Descriptive characteristisc of group with temporal, or temporoparietal focus.  
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 Number Mean SD Min value Max value Median
Lilliefors 
test (p) 
ESS 11 7,54 5,25 1 21 7 0,48 
MSLT 9 14,27 5,57 3,1 20 15,25 0,03 
Eff. of 
sleep 
/%/ 
11 79,08 15,47 50 98 79 0,22 
S1 /%/ 11 26,32 9,63 11,6 40 24,9 0,50 
S2 /%/ 11 41,02 12,90 15,9 67,9 37,8 0,39 
S3+S4 
/%/ 
11 17,13 8,05 1,1 30,6 17,1 0,50 
REM 
/%/ 
11 15,47 7,87 5,1 32,7 15 0,50 
Lat. to 
S1 /min/ 
11 25,50 25,74 1,5 97 17 0,07 
Lat. to 
REM 
/min/ 
11 164,39 114,51 36 378 112,5 0,03 
Table 8b. Descriptive characteristisc of group with frontal of frontotemporal focus.  
 
 
t-test 
(p) 
Kruskal-Wallis 
(p) 
Kolmogor-Smirnov 
(p) 
ESS 0,87 0,98 0,99 
MSLT 0,26 0,19 0,04* 
Ef.sp. /%/ 0,88 0,93 0,77 
S1 /%/ 0,34 0,28 0,66 
S2 /%/ 0,65 0,53 0,51 
S3+S4 /%/ 0,78 0,96 0,96 
REM /%/ 0,13 0,19 0,52 
Lat. to S1 /min/ 0,22 0,68 0,76 
Lat. to REM /min/ 0,98 0,80 0,94 
Table 8c. Comparison of observed parameters in the group with temporal or 
temporoparietal focus and the group with frontal or frontotemporal focus.  
Kolmogov-Smirnov test showed significant difference in mean latency of sleep by MSLT as 
patients with temporal or temporoparietal focus have significantly shorter time in MSLT in 
comparison with group of patients with frontal or frontotemporal focus (see figure 9). 
Though medians of both MSLT tests are in normal range ( > 10 minutes), distribution of 
datas in the group with temporal and temporoparietal localization of focus is more 
disperzed as well as values of short mean latency are presented. This may indicate some 
tendency to elevated daytime sleepiness in the group of patients with temporal or 
temporoparietal localization of epileptic focus.  
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Fig. 9. Mean values of latencies in MSLT in the group with temporal or temporoparietal 
focus (0) and in the group with frontal and frontotemporal focus (1). The difference is 
significant. 
6. Discussion 
Patients in our study as well as control group didn’t have elevated daytime sleepiness 
according to results of Epworth scale of sleepiness (ESS). This result is in accordance with 
literature, where ESS of epileptic patients and healthy controls did not differ significantly 
(Malow et al., 1997; Manni et al., 2000; Watanabe et al., 2003). Patients with epilepsy in our 
group had significantly higher score of ESS than control group. This result was assessed as 
tendency to daytime sleepiness in patients with epilepsy.  
Reason of tendency to problems with vigility in epileptic patients is probably multifactorial. 
We suppose that detemining cause is fragmentation of sleep architecture with failure of its 
restorative functions. We found out significant changes in sleep architecture of epileptic 
patients, which correlate with literature data (Bazil, 2003; Niedermeyer, 1982; Sammaritano 
et al., 1994; Touchon et al., 1991), as significantly lower effectivity of sleep, significantly 
more NREM S2 stage sleep, fewer REM sleep and longer latency to REM sleep. According to 
literature these changes are caused by epileptic seizures, antiepileptic therapy and severity 
of epilepsy (Bazil, Malow & Sammaritano, 2002). We did not prove influence of antiepileptic 
therapy on quality of sleep and daytime vigility. This might be influenced by that patients 
were using medication for longer time before evaluation. Further evaluation should be done 
in this area to determine influence of specific antiepileptic drugs on sleep architecture.  
According to different mechanizms of epileptogenesis in focal and generalized epilepsies 
various centers of brain involved in regulation of sleep may be influenced (Faber, 1995). This 
probably correlates with our results of significant reduction of S3 and S4 NREM sleep in the 
group of patients with focal epilepsy and significant decrement of effectivity of sleep in 
patients with generalized epilepsy. Changes of sleep in focal epilepsy are probably 
influenced by localization and ethiology of laesion, in generalized epilepsy thalamocortical 
circuits involved in epileptogenesis probably influence wider areas of brain.  
That is why localization of epileptic focus was also evaluated in correlation with daytime 
sleepiness and quality of sleep. Significantly shorter mean latency in MSLT was detected in 
patients with temporal focus in comparison with patients with extratemporal epileptic focus. 
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Similar results were published by De Almeida et al. (2003), who referred that patients with 
temporal lobar epilepsy have fragmentation of sleep and reduction of REM sleep.  
7. Conclusion  
Significant changes in sleep architecture of patients with epilepsy were observed, as lower 
effectivity of sleep together with higher amount of NREM S2 sleep and fewer REM sleep. 
These may negatively influence daytime vigility, mental abilities and also compensation of 
epilepsy.  
It was also detected, that patients with generalized epilepsy have lower effectivity of sleep 
and patients with focal epilepsy have fewer deep sleep stages of NREM sleep. 
Some tendency to elevated daytime sleepiness in the group of patients with temporal or 
temporoparietal localization of epileptic focus was proved.  
We recommend awareness among clinicians of the comorbidity of epilepsy and sleep 
disorders as correct diagnostic and therapeutic approach may improve quality of life of 
patients.  
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